Brief: Black Diamond Therapeutics Announces CEO Transition
18/09/2023 12:03
Sept 18 (Reuters) - Black Diamond Therapeutics Inc
BDTX.O :
* BLACK DIAMOND THERAPEUTICS ANNOUNCES CEO TRANSITION
* BLACK DIAMOND THERAPEUTICS INC - MARK VELLECA APPOINTED
CEO
* BLACK DIAMOND THERAPEUTICS INC: VELLECA SUCCEEDS DAVID M.
EPSTEIN
Source text for Eikon: ID:nGNX83f5dt
Further company coverage: BDTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on G1 Therapeutics
See all newsG1 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Abbott Laboratories, Medtronic, Axon
U.S. STOCKS ON THE MOVE-Ralph Lauren, Illumina, Disney
U.S. STOCKS ON THE MOVE-Walt Disney, SpringWorks, Shopify